Michael J. Carson's most recent trade in Nuvectis Pharma Inc was a trade of 61,200 Common Stock done . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 61,200 | 200,118 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,000 | 138,918 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 34,567 | 90,673 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 28,806 | 56,106 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 8.16 per share. | 03 Jan 2023 | 2,755 | 87,918 | - | 8.2 | 22,478 | Common Stock |